Increased levels of IL-15 mRNA in relapsing–remitting multiple sclerosis attacks

This publication has 36 references indexed in Scilit:

• Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells
  Journal of Neuroimmunology, 2001
• The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment
  Multiple Sclerosis Journal, 1998
• The adhesion molecule and cytokine profile of multiple sclerosis lesions
  Annals of Neurology, 1995
• Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity
  Annals of Neurology, 1995
• Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
  Science, 1994
• Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage
  Journal of Neuroimmunology, 1993
• Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.
  Journal of Clinical Investigation, 1991
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Tumor necrosis factor identified in multiple sclerosis brain.
  The Journal of Experimental Medicine, 1989
• Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?
  Acta Neurologica Scandinavica, 1988